Lost in translation : the Canadian access to medicines regime from transnational activism to domestic implementation

Authors: Bubela, Tania; Morin, Jean-Frédéric
Abstract: Canada was the first country to implement the WTO Decision of August 30, 2003, authorizing the export of generic drugs manufactured under a compulsory license to developing countries in response to a proposal brought forward by non-governmental organizations (NGOs) that now claim dissatisfaction with the Canadian legislation. This empirical case study examines what success means for an NGO campaign. It contrasts interviews, documents, media coverage, and public statements of stakeholders, using quantitative and qualitative analyses. It concludes the NGO network experienced a shift from a mobilizer of public sentiment at the international level to a policy adviser at the domestic level. This shift crystallized a change in leadership toward local, rather than transnational NGOs, and a shift in strategy from being radical to more reformist. While this process of institutionalizing the outcomes of international campaigns is necessary for the implementation of international norms into domestic policy, it required NGOs to compromise their ideal positions, producing some objective successes in legislative reform but subjective dissatisfaction of the NGOs in the failure of Canada's domestic regime to enhance access to medicines on the ground in developing countries.
Document Type: Article de recherche
Issue Date: 1 January 2010
Open Access Date: 9 June 2017
Document version: AM
Permalink: http://hdl.handle.net/20.500.11794/14321
This document was published in: Health Law Journal, Vol. 18, 113-157 (2010)
Health Law Institute
Alternative version: 22125973
Collection:Articles publiés dans des revues avec comité de lecture

Files in this item:
Description SizeFormat 
Bubela-Morin Canadian Health Law.pdf634.81 kBAdobe PDFThumbnail
All documents in CorpusUL are protected by Copyright Act of Canada.